OMI-DB Statistics

The OPTIMAM1 project was initiated in 2008, aiming to optimise the adoption of new X-ray technology for detecting breast cancers and thereby to improve the early detection of breast cancers in the NHS Screening Programme. OPTIMAM1 was followed by OPTIMAM2 (2013). The Scientific Computing team, at the Royal Surrey NHS Foundation Trust is responsible for the maintenance of the OPTIMAM Database (OMI-DB), which contains over 8,000,000 processed and unprocessed FFDM, Tomosynthesis and MR images. Screening information is collected from National Breast Screening System (NBSS). Sets of normal, benign and malignant images are selectively collected from multiple NHS sites.

OMI-DB comprises multiple screening datasets (episodes) from multiple clients (cases) who may or may not have been identified with a benign/malignant lesion. Each client's screening dataset contains two views of each breast (medio-lateral oblique and cranio-caudal). Associated tools have been developed to:

  • identify patient cases of interest from the National Breast Screening System (NBSS)
  • automatically retrieve corresponding images from the site’s PACS together with any associated radiological, clinical and pathological data from local databases that may be of interest
  • de-identify collected images
  • allow remote expert radiologists to annotate the images with interesting clinical features and provide descriptors of these features.

All collected cases retrieved from the database are classified as Normal, Benign, Malignant, or Interval Cancers. The Malignant cases are sub-classified into Malignant-Marked and Malignant-Unmarked, depending on if they have been annotated by an OPTIMAM expert image reader or not. The definitions are:

  • Interval Cancer: symptomatic cases in the current year which are classified as malignant after a previous screening appointment at which a client received a normal result and before their next scheduled screening appointment, or previously classified as interval cancer
  • Malignant: cases that are classified as malignant by either surgery, or biopsy, or previously classified as malignant
  • Benign: cases that are classified as benign by either surgery, or biopsy, or previously classified as benign
  • Normal: cases not classified as malignant or benign, or interval cancer

It should be noted that some clients have multiple events in different years.

A high level summary of all data in OMI-DB is given in the table below.

OMI-DB Totals+
Clients857,906
Studies2,444,209
Images11,806,162

Aggregate statistics describing the portion of OMI-DB available for sharing are given in the tables below. These statistics describe the number of clients or episodes for various characteristics of the data.

OMI-DB Totals+
Clients469,359
Studies1,311,413
Images6,998,298
Overall Outcome, Client Count+
Outcome
Malignant15,404
Interval Cancers2,860
Benign11,029
Normal424,339
Unknown15,727
Site, Client Count+
Site
Site 137,268
Site 3681
Site 4103,237
Site 555,444
Site 676,021
Site 776,056
Site 8120,652
Client Age At Screening+
Age
25-292
30-3420
35-3959
40-442,306
45-4964,223
50-54273,303
55-59286,582
60-64261,092
65-69230,764
70-7486,292
75-7914,633
80-844,777
85-89921
90-9487
95-1003
Marked Cases By Client Outcome, Client Count+
Outcome
Malignant Marked7,160
Prior to Interval Cancer Marked83
Benign Marked1,432
Total8,675
Marked Cases By Episode Outcome, Episode Count+
Outcome
Malignant Marked7,320
Prior to Interval Cancer Marked42
Benign Marked1,431
Total9,271
Unprocessed And/ Or Processed Screening Images, Client Count+
Processed only258,929
Unprocessed and Processed209,678
Screening Episode Outcome By Year, Episode Count+
Outcome2009201020112012201320142015201620172018201920202021202220232024
Malignant01077861,3271,6951,9061,6851,6861,6901,5691,36847789716880
Interval Cancer0010010100000000
Prior to Malignant33259761,1041,1751,3091,0821,224998570142157100
Prior to Interval Cancer1582533924434913742922801951002417000
Benign02841,1801,0211,6832,1501,2321,73364954050113323283165
Normal3521,72793,83484,925129,242169,219110,493162,183120,05895,19394,45924,02152,15119,6323,9111,446
Unknown0000010200000000
Screening Episode Outcome, Episode Count+
Outcome
Malignant15,298
Interval Cancer3
Prior to Malignant8,850
Prior to Interval Cancer2,862
Benign11,392
Normal1,175,086
Unknown3
Manufacturer By Year, Episode Count+
Manufacturer2009201020112012201320142015201620172018201920202021202220232024
Hologic3217,36283,31768,726112,204149,87492,319144,450105,85877,47775,48218,12539,56413,1629800
Siemens24,5408,69712,36012,00914,78215,28213,84711,92812,58711,7043,3229,8895,8632,7581,399
GE Healthcare22142,8396,0357,8108,2095,3966,8944,6146,7708,4062,7933,013570850
Philips1299241121111401908900000000
Other/Unknown042181455520200000
Manufacturer, Episode Count+
Manufacturer
Hologic1,011,311
Siemens140,973
GE Healthcare63,805
Philips1,596
Other/Unknown84
Imaging Modality, Client Count+
Modality
Full Field Digital Mammography only458,930
Full Field Digital Mammography and Digital Breast Tomosynthesis10,383
Digital Breast Tomosynthesis only46
Imaging Modality, Episode Count+
Modality
Full Field Digital Mammography only2,064,932
Full Field Digital Mammography and Digital Breast Tomosynthesis10,473
Digital Breast Tomosynthesis only144
Cancer Type, Client Count+
Cancer type
Invasive11,708
In-situ4,010
Cancer Type, Episode Count+
Cancer type
Invasive11,718
In-situ4,016